Skip to content

Marchex, Inc.'s (MCHX) Q2 2025 Financial Results Conference Call Transcript

Marchex, Inc.'s Q2 2025 Earnings Call on August 12, 2025 at 5:00 PM ET, featuring Brian Nagle in the role of Senior VP and Corporate Controller.

Marchex, Inc.'s Q2 2025 Earnings Call Record of Discussion
Marchex, Inc.'s Q2 2025 Earnings Call Record of Discussion

Marchex, Inc.'s (MCHX) Q2 2025 Financial Results Conference Call Transcript

Marchex Inc (MCHX) Reports Q2 2025 Earnings: A Return to Profitability

In a significant development, Marchex Inc (MCHX) has reported a return to profitability in Q2 2025. The company, whose NASDAQ ticker symbol is MCHX, achieved a slight GAAP net income gain compared to a $0.8 million loss in Q2 2024.

The conference call, moderated by Victoria, was presented by Trevor Caldwell, the host and SVP of Corporate Development at Marchex. Participants included Brian Nagle, Edwin A. Miller, Russ Horowitz, and Trevor Caldwell from Marchex, Inc., as well as representatives from Northland Capital Markets and an unidentified participant named Vijay Devar.

Quarterly revenue came in at approximately $11.7 million, representing a year-over-year decline of about 3.5%. EPS for the quarter was $0.01, beating analyst expectations of -$0.01. This positive EPS figure led to a 3% increase in the company's stock price immediately following the earnings release.

Despite the slight revenue decline, Marchex's financial health appears to be improving. The company leverages AI and conversational intelligence to enhance client operational excellence and growth. Recent launches include healthcare AI solutions aimed at better patient insights and marketing attribution.

As of the earnings report, Marchex’s stock traded around $2.03 with significant institutional ownership, including hedge funds such as Jane Street Group acquiring shares recently. Despite beating EPS estimates, the company holds a Hold analyst rating, with some other stocks receiving stronger buy recommendations.

Both GAAP and non-GAAP financial measures were presented during the call. The full transcript of the conference call, which would offer more detailed commentary from management regarding strategic initiatives and outlook, wasn't fully available in the search results.

It's important to note that forward-looking statements were made during the call, and actual results may differ materially. Risks and uncertainties that could cause these results to differ are set forth in today's earnings press release and in Marchex's most recent annual and quarterly report filed with the SEC.

The earnings press release is available in the Investor Relations section of Marchex's website, and a reconciliation of GAAP to non-GAAP measures is included in the release. The conference call was scheduled for August 12, 2025, at 5:00 PM ET.

In summary, Marchex showed improved profitability and exceeded earnings expectations in Q2 2025 despite a modest revenue decline, reflecting a positive step in financial performance amid ongoing efforts to expand AI-driven product offerings.

Read also:

Latest